Search research articles
Contact Us
Filters
Showing results (191-200 of 273) with videos related to
Page
of 28
Sort By:
Radiology
|
April 1, 1989
Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging
E C Unger, T Winokur, P MacDougall, et al.
BMJ (Clinical Research Ed.)
|
May 19, 2001
Microbubble contrast agents: a new era in ultrasound
M J Blomley, J C Cooke, E C Unger, et al.
Magma (New York, N.Y.)
|
September 30, 1999
Gadolinium-containing copolymeric chelates--a new potential MR contrast agent
E C Unger, D Shen, G Wu, et al.
Journal of Computer Assisted Tomography
|
March 1, 1992
CT staging of esophageal carcinoma in patients treated by primary radiation therapy and chemotherapy
E C Unger, L Coia, R Gatenby, et al.
Magnetic Resonance in Medicine
|
June 1, 1996
Microbubbles as novel pressure-sensitive MR contrast agents
A L Alexander, T T McCreery, T R Barrette, et al.
Academic Radiology
|
April 30, 1998
MRX 501: a novel ultrasound contrast agent with therapeutic properties
E C Unger, T McCreery, R Sweitzer, et al.
Archiv Der Pharmazie
|
April 3, 1998
Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy
F Kratz, U Beyer, T Roth, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2012
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours
A Frost, K Mross, S Steinbild, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 1, 1993
Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent
E C Unger, T A Fritz, D Palestrant, et al.
Angiogenesis
|
March 26, 2004
Angiogenesis and the ET-1/ETA receptor system: immunohistochemical expression analysis in bone metastases from patients with different primary tumors
M Medinger, C P Adler, C Schmidt-Gersbach, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 273) with videos related to
Sort By:
Page
of 28
Radiology
|
April 1, 1989
Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging
E C Unger, T Winokur, P MacDougall, et al.
BMJ (Clinical Research Ed.)
|
May 19, 2001
Microbubble contrast agents: a new era in ultrasound
M J Blomley, J C Cooke, E C Unger, et al.
Magma (New York, N.Y.)
|
September 30, 1999
Gadolinium-containing copolymeric chelates--a new potential MR contrast agent
E C Unger, D Shen, G Wu, et al.
Journal of Computer Assisted Tomography
|
March 1, 1992
CT staging of esophageal carcinoma in patients treated by primary radiation therapy and chemotherapy
E C Unger, L Coia, R Gatenby, et al.
Magnetic Resonance in Medicine
|
June 1, 1996
Microbubbles as novel pressure-sensitive MR contrast agents
A L Alexander, T T McCreery, T R Barrette, et al.
Academic Radiology
|
April 30, 1998
MRX 501: a novel ultrasound contrast agent with therapeutic properties
E C Unger, T McCreery, R Sweitzer, et al.
Archiv Der Pharmazie
|
April 3, 1998
Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy
F Kratz, U Beyer, T Roth, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2012
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours
A Frost, K Mross, S Steinbild, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 1, 1993
Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent
E C Unger, T A Fritz, D Palestrant, et al.
Angiogenesis
|
March 26, 2004
Angiogenesis and the ET-1/ETA receptor system: immunohistochemical expression analysis in bone metastases from patients with different primary tumors
M Medinger, C P Adler, C Schmidt-Gersbach, et al.
Page
of 28